NCT04990921View on ClinicalTrials.gov

Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 2, 2021

Primary Completion Date

July 1, 2031

Study Completion Date

July 1, 2031

Conditions
Metastatic Breast Cancer
Interventions
COMBINATION_PRODUCT

Palliative Radiation and Pembrolizumab

Stereotactic radiation therapy will be administered as clinically indicated.

Trial Locations (1)

40202

RECRUITING

James Graham Brown Cancer Center, Louisville

All Listed Sponsors
collaborator

James Graham Brown Cancer Center

OTHER

lead

University of Louisville

OTHER